Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP502282.RA9Cvx-gRbQfV7r_kR7Cbf0Mtd5kA1v-3rM71dhksOj7E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP502282.RA9Cvx-gRbQfV7r_kR7Cbf0Mtd5kA1v-3rM71dhksOj7E130_assertion type Assertion NP502282.RA9Cvx-gRbQfV7r_kR7Cbf0Mtd5kA1v-3rM71dhksOj7E130_head.
- NP502282.RA9Cvx-gRbQfV7r_kR7Cbf0Mtd5kA1v-3rM71dhksOj7E130_assertion description "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502282.RA9Cvx-gRbQfV7r_kR7Cbf0Mtd5kA1v-3rM71dhksOj7E130_provenance.
- NP502282.RA9Cvx-gRbQfV7r_kR7Cbf0Mtd5kA1v-3rM71dhksOj7E130_assertion evidence source_evidence_literature NP502282.RA9Cvx-gRbQfV7r_kR7Cbf0Mtd5kA1v-3rM71dhksOj7E130_provenance.
- NP502282.RA9Cvx-gRbQfV7r_kR7Cbf0Mtd5kA1v-3rM71dhksOj7E130_assertion SIO_000772 19456234 NP502282.RA9Cvx-gRbQfV7r_kR7Cbf0Mtd5kA1v-3rM71dhksOj7E130_provenance.
- NP502282.RA9Cvx-gRbQfV7r_kR7Cbf0Mtd5kA1v-3rM71dhksOj7E130_assertion wasDerivedFrom befree-20140225 NP502282.RA9Cvx-gRbQfV7r_kR7Cbf0Mtd5kA1v-3rM71dhksOj7E130_provenance.
- NP502282.RA9Cvx-gRbQfV7r_kR7Cbf0Mtd5kA1v-3rM71dhksOj7E130_assertion wasGeneratedBy ECO_0000203 NP502282.RA9Cvx-gRbQfV7r_kR7Cbf0Mtd5kA1v-3rM71dhksOj7E130_provenance.